Editorial Comment to Tumor lysis syndrome following cabazitaxel administration for metastatic castration-resistant prostate cancer: A case report

IJU Case Rep. 2019 May 9;2(4):183. doi: 10.1002/iju5.12080. eCollection 2019 Jul.
No abstract available